We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KWR:NYSEQuaker Houghton Analysis

Data as of 2026-05-25 - not real-time

$141.84

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Quaker Chemical is trading well above its discounted cash‑flow estimate, reflecting an **extremely high price‑to‑earnings ratio** that signals overvaluation. The company posted solid revenue growth of roughly eight percent year‑over‑year, yet profit margins remain razor‑thin, with earnings per share barely above breakeven. Operating cash flow is positive, and the dividend payout ratio is unusually low, suggesting the **current dividend is sustainable** despite the weak profitability. Technicals show a neutral price trend, a bearish MACD signal and decreasing volume, placing the stock near its recent support level while still below the identified resistance. Volatility is elevated at over forty percent on a 30‑day basis and beta exceeds 1.3, indicating the stock moves more aggressively than the market. Analyst consensus leans heavily bullish, but the earnings surprise was slightly negative, highlighting a disconnect between expectations and recent performance.
The balance sheet carries a high debt load relative to equity, and return on equity is near zero, raising concerns about long‑term capital efficiency. The forward price‑to‑earnings multiple has collapsed to a more reasonable level, yet the current market price remains far above the DCF fair value, implying limited upside. Sector dynamics for specialty chemicals are mixed, with growth opportunities offset by margin pressure and regulatory scrutiny. Given the combination of overvaluation, high volatility, and modest earnings quality, the stock appears better suited for a cautious stance rather than aggressive buying. Investors should monitor margin trends, debt reduction progress, and any shifts in the technical momentum before adjusting exposure.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish MACD histogram
  • Decreasing volume trend
  • Price near recent support

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Revenue growth outpacing margin expansion
  • Low dividend payout ratio supporting cash flow
  • High debt-to-equity ratio limiting flexibility

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • Current price far above DCF fair value
  • Extremely high trailing PE ratio
  • Near‑zero ROE and elevated volatility

Key Metrics & Analysis

Financial Health

Revenue Growth8.50%
Profit Margin0.22%
P/E Ratio545.5
ROE0.32%
ROA4.34%
Debt/Equity65.95
P/B Ratio1.8
Op. Cash Flow$143.3M
Free Cash Flow$108.4M

Technical Analysis

TrendNeutral
RSI54.6
Support$130.36
Resistance$150.58
MA 20$139.94
MA 50$132.13
MA 200$139.62
MACDBearish
VolumeDecreasing
Fear & Greed Index91.61

Valuation

Fair Value$73.83
Target Price$169.50
Upside/Downside19.50%
GradeOvervalued
TypeGrowth
Dividend Yield1.43%

Risk Assessment

Beta1.40
Volatility41.18%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.